# Fiberoptic Evaluation of i-Gel and Air-Q sp3G Supraglottic Airway Devices in Pediatric Patients

> **NCT07141498** · — · COMPLETED · sponsor: **Ankara City Hospital Bilkent** · enrollment: 91 (actual)

## Conditions studied

- Laryngeal Mask Airways
- Fiberoptic Bronchoscopy (FOB)
- Elective Surgeries
- Gastric Insufflation
- Gastric Ultrasound

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT07141498
- **Lead sponsor:** Ankara City Hospital Bilkent
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2025-08-28
- **Primary completion:** 2025-12-30
- **Final completion:** 2026-01-09
- **Target enrollment:** 91 (ACTUAL)
- **Last updated:** 2026-03-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07141498

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07141498, "Fiberoptic Evaluation of i-Gel and Air-Q sp3G Supraglottic Airway Devices in Pediatric Patients". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT07141498. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
